Hadeel S Hadi, Marwa Ali Hadi, Leqaa Ahmed Aljuranii, Ali A Al-Fahham
{"title":"Respiratory dysfunction in patients with irritable bowel syndrome.","authors":"Hadeel S Hadi, Marwa Ali Hadi, Leqaa Ahmed Aljuranii, Ali A Al-Fahham","doi":"10.36740/Merkur202503108","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Aim: To study the respiratory symptoms and respiratory functions markers in patients with irritable bowel syndrome (IBS).</p><p><strong>Patients and methods: </strong>Materials and Methods: The study included 40 patients with IBS, and 30 apparently healthy subjects. Pulmonary functions are performed using spirometry, including forced expiratory volume, forced vital capacity, Forced Expiratory Volume/Forced Vital Capacity, peak expiratory flow rate. Classification of Irritable Bowel Syndrome subtypes performed according to the Rome III criteria.</p><p><strong>Results: </strong>Results: Respiratory symptom among patients with IBS was sputum in the most common 67.5%, cough 50%, and wheeze 30% and dyspnea 37.5%. The results of the current study also revealed a significant decrease in most markers of respiratory functions markers, these include: Forced Vital Capacity which was (2.59±0.12 L) in Irritable Bowel Syndrome patients as compared to healthy control group (2.82±0.06 L). A significant decrease in Forced Expiratory Volume was also recorded in patients (2.18±0.12 L) comparing to control subjects (2.42±0.73 L). Accordingly, the Forced Expiratory Volume/Forced Vital Capacity was also significantly decreased in patients 83.98%±1.21% in comparison to healthy individuals 85.85%±1.35%.</p><p><strong>Conclusion: </strong>Conclusions: It was concluded that patients with irritable bowel syndrome exhibited a marked decreased in respiratory functions. It also seems that constipation is one of the underlining mechanisms for deterioration in the pulmonary functions and appearance of respiratory symptoms.</p>","PeriodicalId":39518,"journal":{"name":"Polski Merkuriusz Lekarski","volume":"53 3","pages":"347-351"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polski Merkuriusz Lekarski","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36740/Merkur202503108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Aim: To study the respiratory symptoms and respiratory functions markers in patients with irritable bowel syndrome (IBS).
Patients and methods: Materials and Methods: The study included 40 patients with IBS, and 30 apparently healthy subjects. Pulmonary functions are performed using spirometry, including forced expiratory volume, forced vital capacity, Forced Expiratory Volume/Forced Vital Capacity, peak expiratory flow rate. Classification of Irritable Bowel Syndrome subtypes performed according to the Rome III criteria.
Results: Results: Respiratory symptom among patients with IBS was sputum in the most common 67.5%, cough 50%, and wheeze 30% and dyspnea 37.5%. The results of the current study also revealed a significant decrease in most markers of respiratory functions markers, these include: Forced Vital Capacity which was (2.59±0.12 L) in Irritable Bowel Syndrome patients as compared to healthy control group (2.82±0.06 L). A significant decrease in Forced Expiratory Volume was also recorded in patients (2.18±0.12 L) comparing to control subjects (2.42±0.73 L). Accordingly, the Forced Expiratory Volume/Forced Vital Capacity was also significantly decreased in patients 83.98%±1.21% in comparison to healthy individuals 85.85%±1.35%.
Conclusion: Conclusions: It was concluded that patients with irritable bowel syndrome exhibited a marked decreased in respiratory functions. It also seems that constipation is one of the underlining mechanisms for deterioration in the pulmonary functions and appearance of respiratory symptoms.